興業太陽能(00750.HK)重組生效日期預計為12月19日
格隆匯12月16日丨興業太陽能(00750.HK)公佈,百慕達最高法院通過日期為2019年12月4日的命令批准了百慕達安排,且百慕達批准令的正式副本已於2019年12月11日遞給百慕達公司註冊處。香港高等法院通過日期為2019年12月5日的命令批准了香港安排,且香港批准令的正式副本已於2019年12月16日在香港公司註冊處登記。
使香港安排與百慕達安排生效的各個條件均已獲達成,協議安排生效日期為2019年12月16日;及重組生效日期,即香港安排與百慕達安排所規定的安排與妥協將獲實施的日期,預計為2019年12月19日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.